Effect of sleep apnea on cognition and mood

Obstructive sleep apnea syndrome (OSAS) is a common disorder in adults and children, which is characterized by repetitive transient reversible upper airway obstructions during sleep. Due to disrupted sleep architecture and intermittent hypoxemia, OSAS leads to impaired daytime functioning in various neuropsychological and affective domains. The most common abnormalities are executive dysfunction, impaired vigilance, depression, and possibly anxiety and, in children, hyperactivity. Optimal treatment of OSAS with continuous positive airway pressure may reverse the cognitive and affective dysfunction, however, in some patients a residual impairment persists. This persistent deficit, despite effective treatment, raises the possibility of a remaining subtle structural brain damage; such damage has been demonstrated through the use of sensitive functional and other neuroimaging techniques. Prefrontal cortical damage may underlie the cognitive dysfunction in OSAS. Early recognition and treatment may prevent this untoward effect of OSAS.

[1]  D. Giles,et al.  Beta EEG activity and insomnia. , 2001, Sleep medicine reviews.

[2]  R. Farinotti,et al.  Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[3]  E. Bixler,et al.  Insomnia in central Pennsylvania. , 2002, Journal of psychosomatic research.

[4]  D. Clody,et al.  A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine Hypnotic , 1994, Journal of clinical pharmacology.

[5]  E. Bixler,et al.  Biopsychobehavioral correlates of insomnia, III: Polygraphic findings of sleep difficulty and their relationship to psychopathology. , 1984, The International journal of neuroscience.

[6]  Y. Lecrubier,et al.  Form, frequency and burden of sleep problems in general health care: a report from the WHO Collaborative Study on Psychological Problems in General Health Care , 1996, European Psychiatry.

[7]  E. Bixler,et al.  Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. , 2001, The Journal of clinical endocrinology and metabolism.

[8]  F. Richer,et al.  Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). , 1993, Journal of clinical and experimental neuropsychology.

[9]  L. Bailey,et al.  Clinical Pharmacokinetics of Benzodiazipines , 1994, Journal of clinical pharmacology.

[10]  M. Weissman,et al.  The morbidity of insomnia uncomplicated by psychiatric disorders. , 1997, General hospital psychiatry.

[11]  L. Gustavson,et al.  The clinical pharmacokinetics of single doses of estazolam. , 1990, The American journal of medicine.

[12]  C. Mervis,et al.  Sleep and neurobehavioral characteristics of 5- to 7-year-old children with parentally reported symptoms of attention-deficit/hyperactivity disorder. , 2003, Pediatrics.

[13]  E M Badley,et al.  Insomnia and health problems in Canadians. , 2001, Sleep.

[14]  M. Thorpy,et al.  Treatment of chronic insomnia by restriction of time in bed. , 1987, Sleep.

[15]  S. Ancoli-Israel,et al.  Neuropsychological Effects of One-Week Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Placebo-Controlled Study , 2001, Psychosomatic medicine.

[16]  A. Lewy,et al.  Entrainment of free-running circadian rhythms by melatonin in blind people. , 2000, The New England journal of medicine.

[17]  J. Piccirillo,et al.  Learning, Memory, and Executive Control in Individuals With Obstructive Sleep Apnea Syndrome , 2002, Journal of clinical and experimental neuropsychology.

[18]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[19]  E. Rüther,et al.  Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. , 2001 .

[20]  A. Kales,et al.  Sleep and its disorders. , 1999, Annual review of medicine.

[21]  J. Pépin,et al.  Deficits of cognitive executive functions in patients with sleep apnea syndrome. , 1995, Sleep.

[22]  D. Kupfer,et al.  Depressive psychopathology in male sleep apneics. , 1984, The Journal of clinical psychiatry.

[23]  I. Hickie,et al.  Neurobehavioral Functioning in Obstructive Sleep Apnea: Differential Effects of Sleep Quality, Hypoxemia and Subjective Sleepiness , 2004, Journal of clinical and experimental neuropsychology.

[24]  Susan Redline,et al.  Sleep-disordered breathing and cognitive impairment in elderly Japanese-American men. , 2003, Sleep.

[25]  D. Greenblatt,et al.  The International Classification of Sleep Disorders , 1992 .

[26]  J Zieliński,et al.  Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea , 1996, Journal of sleep research.

[27]  Y. Dauvilliers,et al.  Response to "Idiopathic hypersomnia: a diagnostic dilemma" (J. Montplaisir and L. Fantini). , 2001, Sleep medicine reviews.

[28]  P. Benfield,et al.  Zolpidem , 1990, Drugs.

[29]  A. Kales,et al.  Evaluation and Treatment of Insomnia , 1984 .

[30]  E. Bixler,et al.  Biopsychobehavioral Correlates of Insomnia. II. Pattern Specificity and Consistency with the Minnesota Multiphasic Personality Inventory , 1983, Psychosomatic medicine.

[31]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[32]  M. Bianchi,et al.  Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. , 1990, International clinical psychopharmacology.

[33]  Charles M. Morin,et al.  Insomnia: Psychological Assessment and Management , 1993 .

[34]  C. Guilleminault,et al.  Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. , 1984 .

[35]  S. Kuna,et al.  Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. , 2001, American journal of respiratory and critical care medicine.

[36]  R L Williams,et al.  Prevalence of sleep disturbance in a primarily urban Florida County. , 1976, Social science & medicine.

[37]  C. Espie,et al.  Insomniacs' reported use of CBT components and relationship to long-term clinical outcome. , 2002, Behaviour research and therapy.

[38]  N J Douglas,et al.  Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. , 1992, Archives of internal medicine.

[39]  L. Kozlowski,et al.  Over-the-counter sleep aids: Widely used but rarely studied , 1994 .

[40]  Heinz Katschnig,et al.  Diagnostic and statistical manual of mental disorders, third edition, revised (DSM-III-R) , 1992 .

[41]  M Partinen,et al.  Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. , 1990, Chest.

[42]  D. Gozal,et al.  Increased susceptibility to intermittent hypoxia in aging rats: changes in proteasomal activity, neuronal apoptosis and spatial function , 2003, Journal of neurochemistry.

[43]  C. Soldatos,et al.  How do individuals sleep around the world? Results from a single-day survey in ten countries. , 2005, Sleep medicine.

[44]  R. Bootzin,et al.  Nonpharmacologic treatments of insomnia. , 1992, The Journal of clinical psychiatry.

[45]  M. Lader Rebound insomnia and newer hypnotics , 2005, Psychopharmacology.

[46]  W. Mendelson,et al.  MMPI correlates of sleep and respiratory disturbance in obstructive sleep apnea. , 1999, Sleep.

[47]  E. Bixler,et al.  Biopsychobehavioral correlates of insomnia, V: Clinical characteristics and behavioral correlates. , 1984, The American journal of psychiatry.

[48]  R. Freedman,et al.  Physiological and psychological factors in sleep-onset insomnia. , 1982, Journal of abnormal psychology.

[49]  G. Nielsen Brief integrative dynamic psychotherapy for insomnia. Systematic evaluation of two cases. , 1990, Psychotherapy and Psychosomatics.

[50]  R. Millman,et al.  Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. , 1989, The Journal of clinical psychiatry.

[51]  I. Oswald,et al.  Physiological and psychological differences between good and poor sleepers. , 1986, Journal of psychiatric research.

[52]  J. Yager,et al.  Sleep Disorder Over Time: Psychiatric Correlates Among Males , 1980, British Journal of Psychiatry.

[53]  R. Benca Consequences of insomnia and its therapies. , 2001, The Journal of clinical psychiatry.

[54]  F. Richer,et al.  Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. , 1991, Journal of clinical and experimental neuropsychology.

[55]  D. Deptula,et al.  Neuropsychological dysfunction in sleep apnea. , 1987, Sleep.

[56]  M. Scharf,et al.  Comparative amnestic effects of benzodiazepine hypnotic agents. , 1988, The Journal of clinical psychiatry.

[57]  D. Giles,et al.  Temporal and stagewise distribution of high frequency EEG activity in patients with primary and secondary insomnia and in good sleeper controls , 2001, Journal of sleep research.

[58]  C. Marra,et al.  Does cognitive dysfunction conform to a distinctive pattern in obstructive sleep apnea syndrome? , 2004, Journal of sleep research.

[59]  D. Katz,et al.  Clinical correlates of insomnia in patients with chronic illness. , 1998, Archives of internal medicine.

[60]  E. Kozminsky,et al.  Adenotonsillectomy improves neurocognitive function in children with obstructive sleep apnea syndrome. , 2003, Sleep.

[61]  David Gozal,et al.  Neurobehavioral correlates of sleep‐disordered breathing in children , 2004, Journal of sleep research.

[62]  D. Greenblatt,et al.  Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo , 1998, Clinical pharmacology and therapeutics.

[63]  L. Johnson,et al.  Rebound Insomnia: A Critical Review , 1989, Journal of clinical psychopharmacology.

[64]  D. Pevernagie,et al.  Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention. , 2004, Sleep.

[65]  C. Morin,et al.  Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. , 1994, The American journal of psychiatry.

[66]  R. R. Greenson The Technique and Practice of Psychoanalysis, Volume 1 , 1967 .

[67]  J. Owens,et al.  Sleep and Daytime Behavior in Children With Obstructive Sleep Apnea and Behavioral Sleep Disorders , 1998, Pediatrics.

[68]  J. Alger,et al.  Functional magnetic resonance imaging responses to expiratory loading in obstructive sleep apnea , 2003, Respiratory Physiology & Neurobiology.

[69]  E. Bixler,et al.  Next-day memory impairment with triazolam use , 1991, The Lancet.

[70]  P. Hauri,et al.  Persistent psychophysiologic (learned) insomnia. , 1986, Sleep.

[71]  R. Barkin,et al.  A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction. , 1999, Primary care companion to the Journal of clinical psychiatry.

[72]  K. Greenwood,et al.  Identifying effective psychological treatments for insomnia: A meta-analysis. , 1995 .

[73]  L. Lavie,et al.  Obstructive sleep apnoea syndrome--an oxidative stress disorder. , 2003, Sleep medicine reviews.

[74]  Maree Barnes,et al.  A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.

[75]  D. Bliwise Treating insomnia: pharmacological and nonpharmacological approaches. , 1991, Journal of psychoactive drugs.

[76]  T. Roth,et al.  Rebound insomnia: its determinants and significance. , 1990, The American journal of medicine.

[77]  W. Mendelson,et al.  A critical evaluation of the hypnotic efficacy of melatonin. , 1997, Sleep.

[78]  P. Howard Sleep Disorders Classification Committee, Association of Sleep Disorders Centers , 1979 .

[79]  T. Karasu Psychotherapies: an overview. , 1977, The American journal of psychiatry.

[80]  C. Soldatos,et al.  An integrative approach to the management of insomnia , 2003 .

[81]  Vincent Ibanez,et al.  Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. , 2002, Sleep medicine.

[82]  E. Bixler,et al.  Onset of Insomnia: Role of Life‐Stress Events1 , 1981, Psychosomatic medicine.

[83]  D. Gozal,et al.  Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits , 2002, Journal of sleep research.

[84]  P. Hauri Case Studies in Insomnia , 1991 .

[85]  C. Guilleminault,et al.  Insomnia and use of hypnotics: study of a French population. , 1991, Sleep.

[86]  C. Morin,et al.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. , 1999, JAMA.

[87]  J. Watson,et al.  Psychiatric morbidity and illness behaviour in women with chronic pelvic pain. , 1994, Journal of psychosomatic research.

[88]  S. F. Cappa,et al.  Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP) , 2003, Brain Research Bulletin.

[89]  A. Kales,et al.  Sleep disorders: insomnia, sleepwalking, night terrors, nightmares, and enuresis. , 1987, Annals of internal medicine.

[90]  E. Bixler,et al.  Prevalence of sleep disorders in the Los Angeles metropolitan area. , 1979, The American journal of psychiatry.

[91]  M. Ohayon,et al.  What are the contributing factors for insomnia in the general population? , 2001, Journal of psychosomatic research.

[92]  J. D. Ball,et al.  Sleep patterns among children with attention-deficit hyperactivity disorder: a reexamination of parent perceptions. , 1997, Journal of pediatric psychology.

[93]  G. Hajak,et al.  CONSENSUS FOR THE PHARMACOLOGICAL MANAGEMENT OF INSOMNIA IN THE NEW MILLENNIUM , 2001, International journal of clinical practice.

[94]  J. Malin,et al.  Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy , 1998, Journal of the Neurological Sciences.

[95]  M. Schluchter,et al.  Relation of measures of sleep-disordered breathing to neuropsychological functioning. , 2001, American journal of respiratory and critical care medicine.

[96]  A. Kales,et al.  Management of insomnia. , 1979, Annual review of medicine.

[97]  S. Ancoli-Israel,et al.  Effect of CPAP treatment on mood states in patients with sleep apnea. , 1999, Journal of psychiatric research.

[98]  E. Bixler,et al.  Hypnotic effectiveness of sodium salicylamide with short-term use: sleep laboratory studies. , 1978, Pharmacology.

[99]  T. Roth,et al.  Multiple Sleep Latency Test: Technical Aspects and Normal Values , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[100]  M. Bonnet,et al.  Insomnia, metabolic rate and sleep restoration , 2003, Journal of internal medicine.

[101]  Y. Inoue,et al.  Cerebral metabolic impairment in patients with obstructive sleep apnoea: an independent association of obstructive sleep apnoea with white matter change , 2001, Journal of neurology, neurosurgery, and psychiatry.

[102]  Jeffry R Alger,et al.  fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. , 2003, Journal of applied physiology.

[103]  Daniel J Buysse,et al.  The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. , 2004, Sleep medicine reviews.

[104]  C. Soldatos,et al.  Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. , 1999, International clinical psychopharmacology.

[105]  T. Akashiba,et al.  Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. , 2002, Chest.

[106]  S. Ancoli-Israel,et al.  Fatigue in obstructive sleep apnea: driven by depressive symptoms instead of apnea severity? , 2003, The American journal of psychiatry.

[107]  T. Roth,et al.  A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. , 2000, Sleep medicine.

[108]  F. J. Nieto,et al.  Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. , 1999, American journal of respiratory and critical care medicine.

[109]  C. Iber,et al.  Measures of cognitive function in persons with varying degrees of sleep‐disordered breathing: the Sleep Heart Health Study , 2002, Journal of sleep research.

[110]  J. Kelly,et al.  Long-term changes in quality of life after surgery for pediatric obstructive sleep apnea. , 2004, Archives of otolaryngology--head & neck surgery.

[111]  Lisa McLean Overcoming Obstacles: Therapeutic Success Despite External Barriers. , 2002, Primary care companion to the Journal of clinical psychiatry.

[112]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[113]  Mary J Morrell,et al.  Changes in brain morphology associated with obstructive sleep apnea. , 2003, Sleep medicine.

[114]  T. Roth,et al.  Efficacy and Tolerability of 14-Day Administration of Zaleplon 5mg and 10mg for the Treatment of Primary Insomnia , 1998 .

[115]  D. Beebe,et al.  The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. , 2003, Sleep.

[116]  M. Bonnet,et al.  24-Hour metabolic rate in insomniacs and matched normal sleepers. , 1995, Sleep.

[117]  T. Roth,et al.  Effects of acute administration of brotizolam in subjects with disturbed sleep. , 1983, British journal of clinical pharmacology.

[118]  L. J. Monroe Psychological and physiological differences between good and poor sleepers. , 1967, Journal of abnormal psychology.

[119]  J. Broman,et al.  Electrodermal activity in patients with persistent insomnia , 1994, Journal of sleep research.

[120]  Daniel J. Buysse,et al.  Nonpharmacologic Treatment of Chronic Insomnia , 1999, Sleep.

[121]  W. Hao,et al.  A Case—Control Study on Psychological Symptoms in Sleep Apnea-Hypopnea Syndrome , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[122]  P. Lavie,et al.  Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. , 1998, Chest.

[123]  Maurice M Ohayon,et al.  The effects of breathing-related sleep disorders on mood disturbances in the general population. , 2003, The Journal of clinical psychiatry.

[124]  Y. Inoue,et al.  Cerebral metabolism in sleep apnea. Evaluation by magnetic resonance spectroscopy. , 1997, American journal of respiratory and critical care medicine.

[125]  D. Gozal,et al.  Snoring during early childhood and academic performance at ages thirteen to fourteen years. , 2001, Pediatrics.

[126]  Jeffry R Alger,et al.  Brain morphology associated with obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.

[127]  G. Chrousos,et al.  Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. , 2002, Endocrinology and metabolism clinics of North America.

[128]  M. Jadoul,et al.  Obstructive sleep apnoea , 2002, The Lancet.

[129]  C. Soldatos Insomnia in relation to depression and anxiety: epidemiologic considerations. , 1994, Journal of psychosomatic research.

[130]  J. Hedner,et al.  Improvement in Neuropsychological Performance Following Surgical Treatment for Obstructive Sleep Apnea Syndrome , 2002, Acta oto-laryngologica.

[131]  A. Kales,et al.  Severe obstructive sleep apnea--II: Associated psychopathology and psychosocial consequences. , 1985, Journal of chronic diseases.

[132]  M Palta,et al.  Sleep-disordered breathing and neuropsychological deficits. A population-based study. , 1997, American journal of respiratory and critical care medicine.

[133]  S. Ancoli-Israel,et al.  Psychological correlates of sleep apnea. , 1999, Journal of psychosomatic research.

[134]  G. Simon,et al.  Prevalence, burden, and treatment of insomnia in primary care. , 1997, The American journal of psychiatry.

[135]  E. Rüther,et al.  The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia , 2003, Psychopharmacology.